Drug-Eluting Stents Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
Drug-Eluting Stents Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
ID : MRI16197 | Date : Jan, 2021 | Pages :
186 | Region : Global |
Publisher : RI
The Drug-Eluting Stents market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Drug-Eluting Stents market size is expected to gain market growth in the forecast period of 2020 to 2028, with a CAGR of xx%% in the forecast period of 2020 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Rapamycin
Paclitaxel
Everolimus
Others
By Application
Angina Pectoris
Myocardial Infarction
Competitive Landscape and Drug-Eluting Stents Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Boston Scientific
Medtronic, Inc.
Abbott
Lepu Medical
MicroPort Scientific Corporation
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)
Drug-Eluting Stents competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Drug-Eluting Stents sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drug-Eluting Stents sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drug-Eluting Stents market presented in the report. This section sheds light on the sales growth of different regional and country-level Drug-Eluting Stents markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drug-Eluting Stents market.
Region Coverage (Regional Production, Demand & Forecast by Countries etc.): North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Drug-Eluting Stents market for the forecast period 2020 - 2028?
• What are the driving forces in the Drug-Eluting Stents market for the forecast period 2020 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Drug-Eluting Stents industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Table of Contents
1 Drug-Eluting Stents Market Overview
1.1 Drug-Eluting Stents Product Overview
1.2 Drug-Eluting Stents Market Segment by Type
1.2.1 Rapamycin
1.2.2 Paclitaxel
1.2.3 Everolimus
1.2.4 Others
1.3 Global Drug-Eluting Stents Market Size by Type
1.3.1 Global Drug-Eluting Stents Sales and Growth by Type
1.3.2 Global Drug-Eluting Stents Sales and Market Share by Type (2015-2020)
1.3.3 Global Drug-Eluting Stents Revenue and Market Share by Type (2015-2020)
1.3.4 Global Drug-Eluting Stents Price by Type (2015-2020)
2 Global Drug-Eluting Stents Market Competition by Company
2.1 Global Drug-Eluting Stents Sales and Market Share by Company (2015-2020)
2.2 Global Drug-Eluting Stents Revenue and Share by Company (2015-2020)
2.3 Global Drug-Eluting Stents Price by Company (2015-2020)
2.4 Global Top Players Drug-Eluting Stents Manufacturing Base Distribution, Sales Area, Product Types
2.5 Drug-Eluting Stents Market Competitive Situation and Trends
2.5.1 Drug-Eluting Stents Market Concentration Rate
2.5.2 Global Drug-Eluting Stents Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Drug-Eluting Stents Company Profiles and Sales Data
3.1 Boston Scientific
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Drug-Eluting Stents Product Category, Application and Specification
3.1.3 Boston Scientific Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.1.4 Main Business Overview
3.2 Medtronic, Inc.
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Drug-Eluting Stents Product Category, Application and Specification
3.2.3 Medtronic, Inc. Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.2.4 Main Business Overview
3.3 Abbott
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Drug-Eluting Stents Product Category, Application and Specification
3.3.3 Abbott Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.3.4 Main Business Overview
3.4 Lepu Medical
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Drug-Eluting Stents Product Category, Application and Specification
3.4.3 Lepu Medical Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.4.4 Main Business Overview
3.5 MicroPort Scientific Corporation
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Drug-Eluting Stents Product Category, Application and Specification
3.5.3 MicroPort Scientific Corporation Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.5.4 Main Business Overview
3.6 Cook Medical
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Drug-Eluting Stents Product Category, Application and Specification
3.6.3 Cook Medical Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.6.4 Main Business Overview
3.7 Terumo
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Drug-Eluting Stents Product Category, Application and Specification
3.7.3 Terumo Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.7.4 Main Business Overview
3.8 Biosensors International
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Drug-Eluting Stents Product Category, Application and Specification
3.8.3 Biosensors International Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.8.4 Main Business Overview
3.9 Balton
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Drug-Eluting Stents Product Category, Application and Specification
3.9.3 Balton Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.9.4 Main Business Overview
3.10 AlviMedica Medical Technologies
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Drug-Eluting Stents Product Category, Application and Specification
3.10.3 AlviMedica Medical Technologies Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.10.4 Main Business Overview
3.11 Biotronik
3.12 Shandong JW Medical
3.13 Sino Medical
3.14 Beijing AMSINO
3.15 Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)
4 Drug-Eluting Stents Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Drug-Eluting Stents Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Drug-Eluting Stents Sales and Revenue by Regions
4.2.1 Global Drug-Eluting Stents Sales and Market Share by Regions (2015-2020)
4.2.2 Global Drug-Eluting Stents Revenue and Market Share by Regions (2015-2020)
4.2.3 Global Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2015-2020)
4.3 North America Drug-Eluting Stents Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Drug-Eluting Stents Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Drug-Eluting Stents Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Drug-Eluting Stents Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Drug-Eluting Stents Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Drug-Eluting Stents Application/End Users
5.1 Drug-Eluting Stents Segment by Application
5.1.1 Angina Pectoris
5.1.2 Myocardial Infarction
5.2 Global Drug-Eluting Stents Product Segment by Application
5.2.1 Global Drug-Eluting Stents Sales by Application
5.2.2 Global Drug-Eluting Stents Sales and Market Share by Application (2015-2020)
6 Global Drug-Eluting Stents Market Forecast
6.1 Global Drug-Eluting Stents Sales, Revenue Forecast (2021-2028)
6.1.1 Global Drug-Eluting Stents Sales and Growth Rate Forecast (2021-2028)
6.1.1 Global Drug-Eluting Stents Revenue and Growth Rate Forecast (2021-2028)
6.2 Global Drug-Eluting Stents Forecast by Regions
6.2.1 North America Drug-Eluting Stents Sales and Revenue Forecast (2021-2028)
6.2.2 Europe Drug-Eluting Stents Sales and Revenue Forecast (2021-2028)
6.2.3 Asia-Pacific Drug-Eluting Stents Sales and Revenue Forecast (2021-2028)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Drug-Eluting Stents Sales and Revenue Forecast (2021-2028)
6.2.5 Middle East and Africa Drug-Eluting Stents Sales and Revenue Forecast (2021-2028)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Drug-Eluting Stents Forecast by Type
6.3.1 Global Drug-Eluting Stents Sales and Revenue Forecast by Type (2021-2028)
6.3.2 Rapamycin Gowth Forecast
6.3.3 Paclitaxel Gowth Forecast
6.4 Drug-Eluting Stents Forecast by Application
6.4.1 Global Drug-Eluting Stents Sales Forecast by Application (2021-2028)
6.4.2 Global Drug-Eluting Stents Forecast in Angina Pectoris
6.4.3 Global Drug-Eluting Stents Forecast in Myocardial Infarction
7 Drug-Eluting Stents Upstream Raw Materials
7.1 Drug-Eluting Stents Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Drug-Eluting Stents Industrial Chain Analysis
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.